Cathie Wood Trimmed Palantir, But the Bigger Story Is Still Valuation
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
PhonePe to launch UAE operations in its first international market foray
The fintech major has secured two licences from the Central Bank of the UAE to offer consumer payment instruments and e-payment acceptance infrastructure to merchants.
Canadian Dollar: Further gains seen against US Dollar - Scotiabank
Scotiabank strategists Shaun Osborne and Eric Theoret describe the Canadian Dollar (CAD) as steady despite renewed US–Canada trade tensions and targeted import bans.
BoG affirms 8 ± 2% inflation target
According to its July 2026 Monetary Policy Report (MPR), the Central Bank said this will be influenced by the upward revisions in utility tariffs, re-escalation of geopolitical tensions in the Middle East, and the potential impacts of heavy rains on the food supply chain present upside risks to the inflation outlook.
BoG affirms 8 ± 2% inflation target
According to its July 2026 Monetary Policy Report (MPR), the Central Bank said this will be influenced by the upward revisions in utility tariffs, re-escalation of geopolitical tensions in the Middle East, and the potential impacts of heavy rains on the food supply chain present upside risks to the inflation outlook.
BioMarin Reports Positive Phase 3 Results For VOXZOGO
(RTTNews) - BioMarin Pharmaceutical Inc. (BMRN) on Wednesday announced positive Phase 3 results for VOXZOGO (vosoritide) in children with hypochondroplasia, with the study meeting its primary endpoint and all secondary efficacy endpoints.